astar
New Markers For Ovarian Cancer
Researchers have identified two new biomarkers of ovarian cancer, Lgr5 and CHEK2.
Taking The Guesswork Out Of Kidney Cancer
The molecular test kit for kidney cancer helps to classify patients according to their predicted response to existing drugs.
US$160 Million For A*STAR & Industry Joint Semiconductor Labs
The public-private partnership between A*STAR and their industry partners is expected to drive innovative solutions for complex microchip manufacturing.
Wan Yue First Singaporean To Win Branco Weiss Fellowship
Dr. Wan Yue has been awarded the Branco Weiss Fellowship for her work using RNA to tackle antimicrobial resistance.
A*STAR & Roche Develop Cancer Killing Antibodies
Scientists have developed a new approach to cancer treatment: using antibodies which can target and directly kill cancer cells.
“Cryptic Promoters” Drive Stomach Cancer
Using a new technique called Nano-ChIPseq, scientists have found that stomach cancer is driven by mutations in regions of the genome known as cryptic promoters.
Finding New Cancer Drugs With Fluorescent Rotors
Scientists have identified 15 potential cancer drug candidates using a novel fluorescent rotor approach.
100,000 Dpi Nanoprinting Achieved
Super resolution, full color printing is now be possible with a new nanoplasmonic printing method using aluminum disks that can reach 100,000 dpi.
NUCKS Links Obesity To Diabetes
Scientists have identified the molecular link between obesity and diabetes, a transcriptional regulator called NUCKS.
